Company overview
Basic information
Company name
CSO Pharma Baltic, UAB
Company code
300543141
Registered address
Vilnius, J. Galvydžio g. 5, LT-08236
Registration date
2006-02-28
Company age: 20 y. 7 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
https://www.pharmexx.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Temporary employment agency activities and other human resource provisions
Ownership form
Private without foreign capital
UAB "CSO Pharma Baltic"
Company code: 300543141
Address: Vilnius, J. Galvydžio g. 5, LT-08236
Download a detailed company report
Make confident decisions with all the information about CSO Pharma Baltic, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
CSO Pharma Baltic, UAB (company code 300543141) is an operational private limited liability company registered on 28 February 2006. It is a private enterprise within the national private non-financial companies sector, with private ownership in which Lithuanian natural and legal persons hold more than 50% of the authorised capital and no foreign investor capital is included. The company is managed by a CEO with a board/council and is classified as a micro-sized business. Its registered address is J. Galvydžio g. 5, Vilnius, Vilniaus m. sav., Vilniaus apskr.
The company’s main activity is EVRK O.78.20.00, temporary employment agency activities and other human resource provisions. The share capital is EUR 11.9K.
In the latest available financial year, 2024, revenue was EUR 328.3K, down from EUR 420.3K in 2023. Net profit improved from a loss of EUR 7.9K in 2023 to a profit of EUR 7.3K in 2024, with a profit margin of 2.2% in 2024. Equity increased to EUR 48.2K, while total assets reached EUR 74.6K.
The average number of employees declined from 8 in 2023 to 5 in 2024 and to 2 so far in 2026. The average monthly wage was EUR 1,029.03 in 2023 and EUR 777.44 in 2024.
The company’s main activity is EVRK O.78.20.00, temporary employment agency activities and other human resource provisions. The share capital is EUR 11.9K.
In the latest available financial year, 2024, revenue was EUR 328.3K, down from EUR 420.3K in 2023. Net profit improved from a loss of EUR 7.9K in 2023 to a profit of EUR 7.3K in 2024, with a profit margin of 2.2% in 2024. Equity increased to EUR 48.2K, while total assets reached EUR 74.6K.
The average number of employees declined from 8 in 2023 to 5 in 2024 and to 2 so far in 2026. The average monthly wage was EUR 1,029.03 in 2023 and EUR 777.44 in 2024.